Literature DB >> 18071039

Disruptive behavior as a predictor in Alzheimer disease.

Nikolaos Scarmeas1, Jason Brandt, Deborah Blacker, Marilyn Albert, Georgios Hadjigeorgiou, Bruno Dubois, Davangere Devanand, Lawrence Honig, Yaakov Stern.   

Abstract

BACKGROUND: Disruptive behavior is common in Alzheimer disease (AD). There are conflicting reports regarding its ability to predict cognitive decline, functional decline, institutionalization, and mortality.
OBJECTIVE: To examine whether the presence of disruptive behavior has predictive value for important outcomes in AD.
DESIGN: Using the Columbia University Scale for Psychopathology in Alzheimer Disease (administered every 6 months, for a total of 3438 visit-assessments and an average of 6.9 per patient), the presence of disruptive behavior (wandering, verbal outbursts, physical threats/violence, agitation/restlessness, and sundowning) was extracted and examined as a time-dependent predictor in Cox models. The models controlled for the recruitment cohort, recruitment center, informant status, sex, age, education, a comorbidity index, baseline cognitive and functional performance, and neuroleptic use.
SETTING: Five university-based AD centers in the United States and Europe (Predictors Study). PARTICIPANTS: Four hundred ninety-seven patients with early-stage AD (mean Folstein Mini-Mental State Examination score, 20 of 30 at entry) who were recruited and who underwent semiannual follow-up for as long as 14 (mean, 4.4) years. MAIN OUTCOME MEASURES: Cognitive (Columbia Mini-Mental State Examination score, < or = 20 of 57 [approximate Folstein Mini-Mental State Examination score, < or = 10 of 30]) and functional (Blessed Dementia Rating Scale score, parts I and II, > or = 10) ratings, institutionalization equivalent index, and death.
RESULTS: At least 1 disruptive behavioral symptom was noted in 48% of patients at baseline and in 83% at any evaluation. Their presence was associated with increased risks of cognitive decline (hazard ratio 1.45 [95% confidence interval (CI), 1.03-2.03]), functional decline (1.66 [95% CI, 1.17-2.36]), and institutionalization (1.47 [95% CI, 1.10-1.97]). Sundowning was associated with faster cognitive decline, wandering with faster functional decline and institutionalization, and agitation/restlessness with faster cognitive and functional decline. There was no association between disruptive behavior and mortality (hazard ratio, 0.94 [95% CI, 0.71-1.25]).
CONCLUSION: Disruptive behavior is very common in AD and predicts cognitive decline, functional decline, and institutionalization but not mortality.

Entities:  

Mesh:

Year:  2007        PMID: 18071039      PMCID: PMC2690610          DOI: 10.1001/archneur.64.12.1755

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  43 in total

1.  The psychiatric symptoms of Alzheimer's disease.

Authors:  A E Merriam; M K Aronson; P Gaston; S L Wey; I Katz
Journal:  J Am Geriatr Soc       Date:  1988-01       Impact factor: 5.562

2.  Cognitive deterioration in Alzheimer's disease: behavioral and health factors.

Authors:  L Teri; J P Hughes; E B Larson
Journal:  J Gerontol       Date:  1990-03

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Aggressive behavior in persons with dementia who live in the community.

Authors:  M B Ryden
Journal:  Alzheimer Dis Assoc Disord       Date:  1988       Impact factor: 2.703

6.  The impact of dementia on the family.

Authors:  P V Rabins; N L Mace; M J Lucas
Journal:  JAMA       Date:  1982-07-16       Impact factor: 56.272

7.  Predictors and consequences of aggressive behavior by community-based dementia patients.

Authors:  M Hamel; D P Gold; D Andres; M Reis; D Dastoor; H Grauer; H Bergman
Journal:  Gerontologist       Date:  1990-04

8.  Predictors of disease course in patients with probable Alzheimer's disease.

Authors:  Y Stern; R Mayeux; M Sano; W A Hauser; T Bush
Journal:  Neurology       Date:  1987-10       Impact factor: 9.910

9.  Motor signs during the course of Alzheimer disease.

Authors:  N Scarmeas; G M Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; J Brandt; M Albert; K Marder; K Bell; L S Honig; D Wegesin; Y Stern
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

10.  Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.

Authors:  A M Palmer; G C Stratmann; A W Procter; D M Bowen
Journal:  Ann Neurol       Date:  1988-06       Impact factor: 10.422

View more
  37 in total

1.  Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study.

Authors:  Toru Okura; Brenda L Plassman; David C Steffens; David J Llewellyn; Guy G Potter; Kenneth M Langa
Journal:  J Am Geriatr Soc       Date:  2010-01-26       Impact factor: 5.562

2.  Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.

Authors:  Carolyn W Zhu; Elayne E Livote; Kristin Kahle-Wrobleski; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

3.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

4.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

5.  Seizures in Alzheimer disease: who, when, and how common?

Authors:  Nikolaos Scarmeas; Lawrence S Honig; Hyunmi Choi; Julio Cantero; Jason Brandt; Deborah Blacker; Marilyn Albert; Joan C Amatniek; Karen Marder; Karen Bell; W Allen Hauser; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-08

6.  Restless legs syndrome in the darkness of dementia.

Authors:  Georgios M Hadjigeorgiou; Nikolaos Scarmeas
Journal:  Sleep       Date:  2015-03-01       Impact factor: 5.849

7.  Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.

Authors:  Davangere P Devanand; Gregory H Pelton; Kristina D'Antonio; Jesse G Strickler; William C Kreisl; James Noble; Karen Marder; Anne Skomorowsky; Edward D Huey
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jan-Mar       Impact factor: 2.703

8.  Health-care use and cost in dementia caregivers: Longitudinal results from the Predictors Caregiver Study.

Authors:  Carolyn W Zhu; Nikolaos Scarmeas; Katherine Ornstein; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2014-03-15       Impact factor: 21.566

9.  Relapse risk after discontinuation of risperidone in Alzheimer's disease.

Authors:  D P Devanand; Jacobo Mintzer; Susan K Schultz; Howard F Andrews; David L Sultzer; Danilo de la Pena; Sanjay Gupta; Sylvia Colon; Corbett Schimming; Gregory H Pelton; Bruce Levin
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

10.  Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.

Authors:  Lauren P Wadsworth; Natacha Lorius; Nancy J Donovan; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  Dement Geriatr Cogn Disord       Date:  2012-08-28       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.